(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

GLYXAMBI: Oral tablet (10-5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Glyxambi 10mg-5mg Tablet
Drug Image file default-drug-image.png
Glyxambi 10mg-5mg Tablet

What is this Medicine?

EMPAGLIFLOZIN; LINAGLIPTIN (EM pa gli FLOE zin; lin a GLIP tin) is a combination of 2 medicines used to treat type 2 diabetes. This medicine lowers blood sugar. Treatment is combined with a balanced diet and exercise.

CVS Pharmacy Patient Statistics for GLYXAMBI: Oral tablet(10-5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Glyxambi 10mg-5mg Tablet

NDC: 005970182
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 2 Diabetes Mellitus

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Glyxambi 10mg-5mg Tablet

Reported Side Effects for Glyxambi 10mg-5mg Tablet

Infection Incidence:
<7.0%*
Severity: MILD
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Phimosis Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<2.1%*
Severity: MILD
Onset: DELAYED
Nighttime Urination Incidence:
0.3-0.8%*
Severity: MILD
Onset: EARLY
Diuresis Incidence:
0.3-0.5%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
0.3-0.5%*
Severity: MODERATE
Onset: RAPID
Low Blood Volume Incidence:
0.3-0.5%*
Severity: MODERATE
Onset: EARLY
Dehydration Incidence:
0.3-0.5%*
Severity: MODERATE
Onset: DELAYED
Postural Low Blood Pressure Incidence:
0.3-0.5%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
0.3-0.5%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.1-2.3%*
Severity: MILD
Onset: EARLY
Excessive Thirst Incidence:
1.5-1.7%*
Severity: MILD
Onset: EARLY
Inflamed Penis Incidence:
1.6-3.1%*
Severity: MODERATE
Onset: DELAYED
Yeast Infection Incidence:
1.6-6.4%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sugar Incidence:
2.2-3.6%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
2.3-2.4%*
Severity: MILD
Onset: DELAYED
Increased Blood Fats Incidence:
2.9-3.9%*
Severity: MODERATE
Onset: DELAYED
Inceased Urination Incidence:
3.2-3.4%*
Severity: MILD
Onset: EARLY
Increased Urination Incidence:
3.2-3.4%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
3.3%*
Severity: MILD
Onset: EARLY
Vaginal Infection Incidence:
3.7-6.4%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
4.6-6.5%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
5.9-6.6%*
Severity: MILD
Onset: DELAYED
Bladder Infection Incidence:
7.6-12.5%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Glyxambi 10mg-5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Glyxambi 10mg-5mg Tablet(Linagliptin)
Alcohol and Linagliptin(Linagliptin)
Do not take these drugs together without talking to your prescriber. Ethanol may interfere with the actions of Antidiabetic agents. Alcoholic beverages can increase the risk of low blood sugar, or can cause increased blood sugar due to the calories in these beverages. Discuss your drug regimen with your health care provider. Alternative Antidiabetic Agents may be considered.
Moderate Lifestyle Interaction
Alcohol and Glyxambi 10mg-5mg Tablet(Empagliflozin)
Alcohol and Empagliflozin(Empagliflozin)
Ethanol may interfere with the actions of Empagliflozin. Alcoholic beverages can increase the risk of low blood sugar, or can cause increased blood sugar due to the calories in these beverages. Limit alcohol containing medicines and beverages if you are on Antidiabetic Agents. You should also learn how to recognize the signs of low blood sugar.
Minor Lifestyle Interaction
Tobacco and Glyxambi 10mg-5mg Tablet(Linagliptin)
Tobacco and Linagliptin(Linagliptin)
If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the action of linagliptin may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.
Minor Lifestyle Interaction
Tobacco and Glyxambi 10mg-5mg Tablet(Empagliflozin)
Tobacco and Empagliflozin(Empagliflozin)
If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the actions of Antidiabetic Agents (medicines used to treat diabetes) may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with GLYXAMBI

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.